Contemporary Reoperative Mitral Valve Surgery: Technical Considerations and Clinical Outcomes

Abstract

As patients with cardiac disease live longer, reoperative mitral valve surgery has become more common. Although these operations are technically challenging and of high risk, outcomes continue to improve. Minimally invasive techniques, better cardioprotective strategies, and advanced perioperative care have contributed to this. In this review, we discuss surgical approaches, intraoperative strategies, novel catheter-directed devices, and clinical outcomes of contemporary reoperative mitral valve surgery.

Keywords

reoperative mitral valve surgery minimally invasive surgery mitral valve surgery surgical considerations catheter-directed devices clinical outcomes

Get full access to this article

View all access options for this article.

References

Cetinkaya

Poggenpohl

Bramlage

et al. Long-term outcome after mitral valve replacement using biological versus mechanical valves. J Cardiothorac Surg 2019; 14: 120.doi:10.1186/s13019-019-0943-6

http://www.ncbi.nlm.nih.gov/pubmed/31253187

Vohra

HA.

Whistance

RN.

Roubelakis

et al. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg 2012; 14: 575–579.doi:10.1093/icvts/ivs005

http://www.ncbi.nlm.nih.gov/pubmed/22294560

Zegdi

Sleilaty

Latrémouille

et al. Reoperation for failure of mitral valve repair in degenerative disease: a single-center experience. Ann Thorac Surg 2008; 86: 1480–1484.doi:10.1016/j.athoracsur.2008.07.020

http://www.ncbi.nlm.nih.gov/pubmed/19049735

Mehaffey

HJ.

Hawkins

RB.

Schubert

et al. Contemporary outcomes in reoperative mitral valve surgery. Heart 2018; 104: 652–656.doi:10.1136/heartjnl-2017-312047

http://www.ncbi.nlm.nih.gov/pubmed/28982718

Husebye

DG.

Pluth

JR.

Piehler

et al. Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients. J Thorac Cardiovasc Surg 1983; 86: 543–552.http://www.ncbi.nlm.nih.gov/pubmed/6621082

Sampath Kumar

Dhareshwar

Airan

et al. Redo mitral valve surgery-a long-term experience. J Card Surg 2004; 19: 303–307.doi:10.1111/j.0886-0440.2004.4054_11.x

http://www.ncbi.nlm.nih.gov/pubmed/15245458

Romano

MA.

Haft

JW.

Pagani

et al. Beating heart surgery via right thoracotomy for reoperative mitral valve surgery: a safe and effective operative alternative. J Thorac Cardiovasc Surg 2012; 144: 334–339.doi:10.1016/j.jtcvs.2011.09.026

http://www.ncbi.nlm.nih.gov/pubmed/22050983

Potter

DD.

Sundt, 3rd

TM.

Zehr

et al. Risk of repeat mitral valve replacement for failed mitral valve prostheses. Ann Thorac Surg 2004; 78: 67–72.doi:10.1016/j.athoracsur.2004.02.014

15223405

Borger

MA.

Yau

TM.

Rao

et al. Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus. Ann Thorac Surg 2002; 74: 1482–1487.doi:10.1016/S0003-4975(02)03950-4

http://www.ncbi.nlm.nih.gov/pubmed/12440596

10.

David

TE.

Ivanov

Armstrong

et al. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg 2005; 130: 1242–1249.doi:10.1016/j.jtcvs.2005.06.046

http://www.ncbi.nlm.nih.gov/pubmed/16256774

11.

Castillo

JG.

Anyanwu

AC.

Fuster

et al. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg 2012; 144: 308–312.doi:10.1016/j.jtcvs.2011.12.054

http://www.ncbi.nlm.nih.gov/pubmed/22698565

12.

Cooley

. Review of Carpentier's reconstructive valve surgery: from valve analysis to valve reconstruction. Tex Heart Inst J 2010; 37: 382.

13.

Jamieson

WRE.

Burr

LH.

Miyagishima

et al. Re-operation for bioprosthetic aortic structural failure - risk assessment. Eur J Cardiothorac Surg 2003; 24: 873–878.doi:10.1016/S1010-7940(03)00566-9

http://www.ncbi.nlm.nih.gov/pubmed/14643803

14.

Jamieson

WR.

Burr

LH.

Miyagishima

et al. Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprostheses. Can J Cardiol 1999; 15: 973–978.http://www.ncbi.nlm.nih.gov/pubmed/10504178

15.

Akins

. Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 1995; 60: 1836–1844.doi:10.1016/0003-4975(95)00766-0

http://www.ncbi.nlm.nih.gov/pubmed/8787503

16.

Anyanwu

AC.

Itagaki

Varghese

et al. Re-repair of the mitral valve as a primary strategy for early and late failures of mitral valve repair. Eur J Cardiothorac Surg 2014; 45: 352–358.doi:10.1093/ejcts/ezt256

http://www.ncbi.nlm.nih.gov/pubmed/23864217

17.

Jamieson

WRE.

Burr

LH.

Miyagishima

et al. Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation 2003; 108: II98–II102.doi:10.1161/01.cir.0000089184.46999.f4

http://www.ncbi.nlm.nih.gov/pubmed/12970216

18.

Jaussaud

Gariboldi

Grisoli

et al. Risk of reoperation for mitral bioprosthesis dysfunction. J Heart Valve Dis 2012; 21: 56–60.http://www.ncbi.nlm.nih.gov/pubmed/22474743

19.

Ejiofor

JI.

Hirji

SA.

Ramirez-Del Val

et al. Outcomes of repeat mitral valve replacement in patients with prior mitral surgery: a benchmark for transcatheter approaches. J Thorac Cardiovasc Surg 2018; 156: 619–627.doi:10.1016/j.jtcvs.2018.03.126

http://www.ncbi.nlm.nih.gov/pubmed/29759741

20.

Barbero

Marchetto

Ricci

et al. Right minithoracotomy for mitral valve surgery: impact of tailored strategies on early outcome. Ann Thorac Surg 2016; 102: 1989–1994.doi:10.1016/j.athoracsur.2016.04.104

http://www.ncbi.nlm.nih.gov/pubmed/27435516

21.

Murzi

Miceli

Di Stefano

et al. Minimally invasive right thoracotomy approach for mitral valve surgery in patients with previous sternotomy: a single institution experience with 173 patients. J Thorac Cardiovasc Surg 2014; 148: 2763–2768.doi:10.1016/j.jtcvs.2014.07.108

http://www.ncbi.nlm.nih.gov/pubmed/25224550

22.

Ramchandani

Al Jabbari

Abu Saleh

et al. Cannulation strategies and pitfalls in minimally invasive cardiac surgery. Methodist Debakey Cardiovasc J 2016; 12: 10–13.doi:10.14797/mdcj-12-1-10

http://www.ncbi.nlm.nih.gov/pubmed/27127556

23.

Svensson

LG.

Blackstone

EH.

Rajeswaran

et al. Does the arterial cannulation site for circulatory arrest influence stroke risk? Ann Thorac Surg 2004; 78: 1274–1284.doi:10.1016/j.athoracsur.2004.04.063

http://www.ncbi.nlm.nih.gov/pubmed/15464485

24.

Schwartz

DS.

Ribakove

GH.

Grossi

et al. Minimally invasive cardiopulmonary bypass with cardioplegic arrest: a closed chest technique with equivalent myocardial protection. J Thorac Cardiovasc Surg 1996; 111: 556–566.doi:10.1016/S0022-5223(96)70307-0

http://www.ncbi.nlm.nih.gov/pubmed/8601970

25.

Glower

DD.

Desai

. Transaortic endoclamp for mitral valve operation through right minithoracotomy in 369 patients. Innovations 2010; 5: 394–399.doi:10.1177/155698451000500603

http://www.ncbi.nlm.nih.gov/pubmed/22437633

26.

Van Nooten

Van Belleghem

Van Overbeke

et al. Redo mitral surgery using the Estech endoclamp. Heart Surg Forum 2001; 4: 31–33.http://www.ncbi.nlm.nih.gov/pubmed/11502494

27.

Onnasch

JF.

Schneider

Falk

et al. Minimally invasive approach for redo mitral valve surgery: a true benefit for the patient. J Card Surg 2002; 17: 14–19.doi:10.1111/j.1540-8191.2001.tb01214.x

http://www.ncbi.nlm.nih.gov/pubmed/12027121

28.

Maselli

Pizio

Borelli

et al. Endovascular balloon versus transthoracic aortic clamping for minimally invasive mitral valve surgery: impact on cerebral microemboli. Interact Cardiovasc Thorac Surg 2006; 5: 183–186.doi:10.1510/icvts.2005.123372

http://www.ncbi.nlm.nih.gov/pubmed/17670543

29.

Luo

Shi

et al. Single-dose del Nido cardioplegia used in adult minimally invasive valve surgery. J Thorac Dis 2019; 11: 2373–2382.doi:10.21037/jtd.2019.05.78

30.

Hummel

BW.

Buss

RW.

DiGiorgi

et al. Myocardial protection and financial considerations of custodiol cardioplegia in minimally invasive and open valve surgery. Innovations 2016; 11: 420–424.doi:10.1097/imi.0000000000000314

http://www.ncbi.nlm.nih.gov/pubmed/27879532

31.

Mojena

GC.

Taín

Paredes

et al. A comparison of beating heart and arrested heart techniques for mitral valve replacement surgery. MEDICC Rev 2009; 11: 36–41.21483325

32.

Kitamura

Stuklis

RG.

Edwards

. Redo mitral valve operation via right minithoracotomy-"no touch" technique. Int Heart J 2011; 52: 107–109.doi:10.1536/ihj.52.107

http://www.ncbi.nlm.nih.gov/pubmed/21483170

33.

Holmes

SD.

Shuman

et al. Minimally invasive mitral valve surgery without aortic cross-clamping and with femoral cannulation is not associated with increased risk of stroke compared with traditional mitral valve surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg 2015; 48: 868–872.doi:10.1093/ejcts/ezv017

http://www.ncbi.nlm.nih.gov/pubmed/25646401

34.

Dubost

Guilmet

de Parades

et al. New technic of opening of the left auricle in open-heart surgery: the transseptal bi-auricular approach. Presse Med 1966; 74: 1607–1608.http://www.ncbi.nlm.nih.gov/pubmed/5932446

35.

Brawley

. Improved exposure of the mitral valve in patients with a small left atrium. Ann Thorac Surg 1980; 29: 179–181.doi:10.1016/S0003-4975(10)61660-8

http://www.ncbi.nlm.nih.gov/pubmed/7356370

36.

Guiraudon

GM.

Ofiesh

JG.

Kaushik

. Extended vertical transatrial septal approach to the mitral valve. Ann Thorac Surg 1991; 52: 1058–1062.doi:10.1016/0003-4975(91)91281-Y

http://www.ncbi.nlm.nih.gov/pubmed/1953124

37.

Kim

GS.

Beom

MS.

Kim

et al. Modified surgical intervention for extensive mitral valve endocarditis and posterior mitral annular calcification. Korean J Thorac Cardiovasc Surg 2016; 49: 46–49.doi:10.5090/kjtcs.2016.49.1.46

http://www.ncbi.nlm.nih.gov/pubmed/26889447

38.

Bedeir

Kaneko

Aranki

. Current and evolving strategies in the management of severe mitral annular calcification. J Thorac Cardiovasc Surg 2019; 157: 555–566.doi:10.1016/j.jtcvs.2018.05.099

http://www.ncbi.nlm.nih.gov/pubmed/30385026

39.

David

TE.

Feindel

CM.

Armstrong

et al. Reconstruction of the mitral anulus. J Thorac Cardiovasc Surg 1995; 110: 1323–1332.doi:10.1016/S0022-5223(95)70055-2

40.

Nishida

Fukui

Kasegawa

et al. Causes of repair failure for degenerative mitral valve disease and reoperation outcomes. Eur J Cardiothorac Surg 2018; 53: 1244–1250.doi:10.1093/ejcts/ezx468

http://www.ncbi.nlm.nih.gov/pubmed/29309559

41.

Aphram

De Kerchove

Mastrobuoni

et al. Re-repair of the failed mitral valve: insights into aetiology and surgical management. Eur J Cardiothorac Surg 2018; 54: 774–780.doi:10.1093/ejcts/ezy111

http://www.ncbi.nlm.nih.gov/pubmed/29547941

42.

Gillinov

AM.

Cosgrove

DM.

Lytle

et al. Reoperation for failure of mitral valve repair. J Thorac Cardiovasc Surg 1997; 113: 467–475.doi:10.1016/S0022-5223(97)70359-3

http://www.ncbi.nlm.nih.gov/pubmed/9081091

43.

Shekar

PS.

Couper

GS.

Cohn

. Mitral valve re-repair. J Heart Valve Dis 2005; 14: 583–587.http://www.ncbi.nlm.nih.gov/pubmed/16245495

44.

Kilic

Helmers

MR.

Han

et al. Redo mitral valve surgery following prior mitral valve repair. J Card Surg 2018; 33: 772–777.doi:10.1111/jocs.13944

http://www.ncbi.nlm.nih.gov/pubmed/30548701

45.

Suri

RM.

Schaff

HV.

Dearani

et al. Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired? J Thorac Cardiovasc Surg 2006; 132: 1390–1397.doi:10.1016/j.jtcvs.2006.07.018

http://www.ncbi.nlm.nih.gov/pubmed/17140963

46.

Seeburger

Borger

MA.

Falk

et al. Minimally invasive mitral valve surgery after previous sternotomy: experience in 181 patients. Ann Thorac Surg 2009; 87: 709–714.doi:10.1016/j.athoracsur.2008.11.053

http://www.ncbi.nlm.nih.gov/pubmed/19231375

47.

Akay

TH.

Gultekin

Ozkan

et al. Mitral valve replacements in redo patients with previous mitral valve procedures: mid-term results and risk factors for survival. J Card Surg 2008; 23: 415–421.doi:10.1111/j.1540-8191.2008.00630.x

http://www.ncbi.nlm.nih.gov/pubmed/18928480

48.

Kothari

Patel

Brahmbhatt

et al. Redo mitral valve replacement for prosthetic valve thrombosis: single center experience. J Clin Diagn Res 2016; 10: PC01–PC03.doi:10.7860/JCDR/2016/20209.8913

http://www.ncbi.nlm.nih.gov/pubmed/28050429

49.

Matsuyama

Matsumoto

Sugita

et al. Long-term results of reoperative mitral valve surgery in patients with rheumatic disease. Ann Thorac Surg 2003; 76: 1939–1943.doi:10.1016/S0003-4975(03)01061-0

http://www.ncbi.nlm.nih.gov/pubmed/14667617

50.

Suzuki

Pagani

FD.

Bolling

. Left thoracotomy for multiple-time redo mitral valve surgery using on-pump beating heart technique. Ann Thorac Surg 2008; 86: 466–471.doi:10.1016/j.athoracsur.2008.04.050

http://www.ncbi.nlm.nih.gov/pubmed/18640318

51.

Castillo-Sang

Guthrie

TJ.

Moon

et al. Outcomes of repeat mitral valve surgery in patients with pulmonary hypertension. Innovations 2015; 10: 120–124.doi:10.1097/imi.0000000000000139

http://www.ncbi.nlm.nih.gov/pubmed/25803772

52.

Meyer

SR.

Szeto

WY.

Augoustides

et al. Reoperative mitral valve surgery by the port access minithoracotomy approach is safe and effective. Ann Thorac Surg 2009; 87: 1426–1430.

53.

Trehan

Mishra

YK.

Mathew

et al. Redo mitral valve surgery using the port-access system. Asian Cardiovasc Thorac Ann 2002; 10: 215–218.doi:10.1177/021849230201000305

http://www.ncbi.nlm.nih.gov/pubmed/12213742

54.

Onorati

Gatti

Perrotti

et al. Impact of failed mitral valve repair on hospital outcome of redo mitral valve procedures. Eur J Cardiothorac Surg 2017; 51: 906–912.doi:10.1093/ejcts/ezw436

http://www.ncbi.nlm.nih.gov/pubmed/28204140

55.

Lagercrantz

Lindblom

Sartipy

. Survival and quality of life in cardiac surgery patients with prolonged intensive care. Ann Thorac Surg 2010; 89: 490–495.doi:10.1016/j.athoracsur.2009.09.073

http://www.ncbi.nlm.nih.gov/pubmed/20103328

56.

Walther

Falk

Metz

et al. Pain and quality of life after minimally invasive versus conventional cardiac surgery. Ann Thorac Surg 1999; 67: 1643–1647.doi:10.1016/S0003-4975(99)00284-2

http://www.ncbi.nlm.nih.gov/pubmed/10391268

57.

Kara

KA.

Caner

. Comparison of pain in the early post-operative period using VAS score in patients after cardiac surgery who had minimally invasive incisions vs. full median sternotomy. Ann Ital Chir 2019; 90: 3–9.http://www.ncbi.nlm.nih.gov/pubmed/30394365

58.

Al Otaibi

Gupta

Belley-Cote

et al. Mini-thoracotomy vs. conventional sternotomy mitral valve surgery: a systematic review and meta-analysis. J Cardiovasc Surg 2017; 58: 489–496.doi:10.23736/S0021-9509.16.09603-8

http://www.ncbi.nlm.nih.gov/pubmed/27588617

59.

Cao

Gupta

Chandrakumar

et al. A meta-analysis of minimally invasive versus conventional mitral valve repair for patients with degenerative mitral disease. Ann Cardiothorac Surg 2013; 2: 693–703.

60.

Svensson

LG.

Atik

FA.

Cosgrove

et al. Minimally invasive versus conventional mitral valve surgery: a propensity-matched comparison. J Thorac Cardiovasc Surg 2010; 139: 926–932.doi:10.1016/j.jtcvs.2009.09.038

http://www.ncbi.nlm.nih.gov/pubmed/19945121

61.

Speziale

Nasso

Esposito

et al. Results of mitral valve repair for Barlow disease (bileaflet prolapse) via right minithoracotomy versus conventional median sternotomy: a randomized trial. J Thorac Cardiovasc Surg 2011; 142: 77–83.doi:10.1016/j.jtcvs.2010.08.033

http://www.ncbi.nlm.nih.gov/pubmed/20926105

62.

Botta

Cannata

Bruschi

et al. Minimally invasive approach for redo mitral valve surgery. J Thorac Dis 2013; 5: S686–S693.doi:10.3978/j.issn.2072-1439.2013.10.12

http://www.ncbi.nlm.nih.gov/pubmed/24251029

63.

Balsam

LB.

Grossi

EA.

Greenhouse

et al. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg 2010; 90: 1195–1201.doi:10.1016/j.athoracsur.2010.04.057

http://www.ncbi.nlm.nih.gov/pubmed/20868814

64.

Sorajja

Vemulapalli

Feldman

et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT Registry report. J Am Coll Cardiol 2017; 70: 2315–2327.doi:10.1016/j.jacc.2017.09.015

http://www.ncbi.nlm.nih.gov/pubmed/29096801

65.

Del Val

Ferreira-Neto

AN.

Wintzer-Wehekind

et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc 2019; 8: e013332.doi:10.1161/JAHA.119.013332

http://www.ncbi.nlm.nih.gov/pubmed/31441371

66.

Yoon

S-H.

Whisenant

BK.

Bleiziffer

et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019; 40: 441–451.doi:10.1093/eurheartj/ehy590

http://www.ncbi.nlm.nih.gov/pubmed/30357365

67.

Guerrero

Vemulapalli

Xiang

et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States: data from the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv 2020; 13: e008425.doi:10.1161/CIRCINTERVENTIONS.119.008425

http://www.ncbi.nlm.nih.gov/pubmed/32138529

68.

Regueiro

Fam

et al. 2-Year outcomes after transcatheter mitral valve replacement. JACC Cardiovasc Interv 2017; 10: 1671–1678.doi:10.1016/j.jcin.2017.05.032

http://www.ncbi.nlm.nih.gov/pubmed/28838478

69.

Sondergaard

Brooks

Ihlemann

et al. Transcatheter mitral valve implantation via transapical approach: an early experience. Eur J Cardiothorac Surg 2015; 48: 873–878.doi:10.1093/ejcts/ezu546

http://www.ncbi.nlm.nih.gov/pubmed/25653251

70.

Cheung

. Early experience of TIARA transcatheter mitral valve replacement system. Ann Cardiothorac Surg 2018; 7: 787–791.doi:10.21037/acs.2018.09.05

http://www.ncbi.nlm.nih.gov/pubmed/30598894

71.

Sorajja

Moat

Badhwar

et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol 2019; 73: 1250–1260.doi:10.1016/j.jacc.2018.12.066

http://www.ncbi.nlm.nih.gov/pubmed/30898200

72.

Bapat

Rajagopal

Meduri

et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol 2018; 71: 12–21.doi:10.1016/j.jacc.2017.10.061

73.

Webb

JG.

Murdoch

DJ.

Boone

et al. Percutaneous transcatheter mitral valve replacement: first-in-human experience with a new transseptal system. J Am Coll Cardiol 2019; 73: 1239–1246.doi:10.1016/j.jacc.2018.12.065

http://www.ncbi.nlm.nih.gov/pubmed/30898198

74.

Munkholm-Larsen

Wan

Tian

et al. A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates. Heart 2014; 100: 473–478.doi:10.1136/heartjnl-2013-304049

http://www.ncbi.nlm.nih.gov/pubmed/23813844

75.

Mahabir

CA.

DeFilippis

EM.

Aggarwal

et al. The first 4 years of postmarketing safety surveillance related to the MitraClip device: a United States Food and Drug Administration MAUDE experience. J Invasive Cardiol 2020; 32: E130–E132.http://www.ncbi.nlm.nih.gov/pubmed/32269176

76.

Orban

Lüsebrink

Braun

et al. Recent advances in patient selection and devices for transcatheter edge-to-edge mitral valve repair in heart failure. Expert Rev Med Devices 2020; 17: 93–102.doi:10.1080/17434440.2020.1714433

http://www.ncbi.nlm.nih.gov/pubmed/31923376

77.

Sorajja

Mack

Vemulapalli

et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol 2016; 67: 1129–1140.doi:10.1016/j.jacc.2015.12.054

78.

Whitlow

PL.

Feldman

Pedersen

et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012; 59: 130–139.doi:10.1016/j.jacc.2011.08.067

http://www.ncbi.nlm.nih.gov/pubmed/22222076

79.

Stone

GW.

Lindenfeld

Abraham

et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018; 379: 2307–2318.doi:10.1056/NEJMoa1806640

http://www.ncbi.nlm.nih.gov/pubmed/30280640

80.

Obadia

J-F.

Messika-Zeitoun

Leurent

et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018; 379: 2297–2306.doi:10.1056/NEJMoa1805374

http://www.ncbi.nlm.nih.gov/pubmed/30145927

81.

Tabata

Weber

Sinning

J-M

et al. Successful edge-to-edge mitral repair using the new MitraClip XTR System following rupture of transapical implanted NeoChord. JACC Cardiovasc Interv 2018; 11: e175–e177.doi:10.1016/j.jcin.2018.08.030

http://www.ncbi.nlm.nih.gov/pubmed/30343017

82.

Tabata

Sugiura

Tsujita

et al. Percutaneous interventions for mitral and tricuspid heart valve diseases. Cardiovasc Interv Ther 2020; 35: 62–71.doi:10.1007/s12928-019-00610-z

http://www.ncbi.nlm.nih.gov/pubmed/31396890

83.

Kriechbaum

SD.

Boeder

NF.

Gaede

et al. Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience. Clin Res Cardiol 2020; 109: 549–559.doi:10.1007/s00392-019-01538-3

http://www.ncbi.nlm.nih.gov/pubmed/31451915

84.

Praz

Spargias

Chrissoheris

et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 2017; 390: 773–780.doi:10.1016/S0140-6736(17)31600-8

http://www.ncbi.nlm.nih.gov/pubmed/28831993

85.

Maisano

Taramasso

Nickenig

et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 2016; 37: 817–825.doi:10.1093/eurheartj/ehv603

http://www.ncbi.nlm.nih.gov/pubmed/26586779

86.

Nickenig

Hammerstingl

Schueler

et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the Cardioband percutaneous mitral repair system. JACC Cardiovasc Interv 2016; 9: 2039–2047.doi:10.1016/j.jcin.2016.07.005

http://www.ncbi.nlm.nih.gov/pubmed/27712741

87.

Taramasso

Alessandrini

Latib

et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the International TriValve Registry. JACC Cardiovasc Interv 2019; 12: 155–165.doi:10.1016/j.jcin.2018.10.022

http://www.ncbi.nlm.nih.gov/pubmed/30594510

88.

Maisano

Taramasso

. The Cardioband transcatheter direct mitral valve annuloplasty system. EuroIntervention 2015; 11: W58–W59.doi:10.4244/EIJV11SWA15

http://www.ncbi.nlm.nih.gov/pubmed/26384192

89.

Miller

Thourani

VH.

Whisenant

. The Cardioband transcatheter annular reduction system. Ann Cardiothorac Surg 2018; 7: 741–747.doi:10.21037/acs.2018.10.10

http://www.ncbi.nlm.nih.gov/pubmed/30598887

90.

Weber

Öztürk

Taramasso

et al. Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation. Euro Intervention 2019; 15: 912–918.doi:10.4244/EIJ-D-19-00468

http://www.ncbi.nlm.nih.gov/pubmed/31113764

91.

Nickenig

Schueler

Dager

et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system. J Am Coll Cardiol 2016; 67: 2927–2936.doi:10.1016/j.jacc.2016.03.591

http://www.ncbi.nlm.nih.gov/pubmed/27339489

92.

Schofer

Siminiak

Haude

et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 2009; 120: 326–333.doi:10.1161/CIRCULATIONAHA.109.849885

http://www.ncbi.nlm.nih.gov/pubmed/19597051

93.

Siminiak

JC.

Haude

et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 2012; 14: 931–938.doi:10.1093/eurjhf/hfs076

http://www.ncbi.nlm.nih.gov/pubmed/22613584

94.

Lipiecki

Siminiak

Sievert

et al. Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial. Open Heart 2016; 3: e000411.doi:10.1136/openhrt-2016-000411

27493761

95.

Goldberg

SL.

Meredith

Marwick

et al. A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-trial design of the REDUCE FMR study. Am Heart J 2017; 188: 167–174.doi:10.1016/j.ahj.2017.02.032

http://www.ncbi.nlm.nih.gov/pubmed/28577672

96.

Rucinskas

Janusauskas

Zakarkaite

et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg 2014; 147: 95–99.doi:10.1016/j.jtcvs.2013.08.012

http://www.ncbi.nlm.nih.gov/pubmed/24100100

97.

Seeburger

Rinaldi

Nielsen

et al. Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. J Am Coll Cardiol 2014; 63: 914–919.doi:10.1016/j.jacc.2013.07.090

http://www.ncbi.nlm.nih.gov/pubmed/24076529

98.

Colli

Bizzotto

Manzan

et al. Patient-specific ventricular access site selection for the NeoChord mitral valve repair procedure. Ann Thorac Surg 2017; 104: e199–e202.doi:10.1016/j.athoracsur.2017.03.082

http://www.ncbi.nlm.nih.gov/pubmed/28734454

99.

Colli

Adams

Fiocco

et al. Transapical NeoChord mitral valve repair. Ann Cardiothorac Surg 2018; 7: 812–820.doi:10.21037/acs.2018.11.04

http://www.ncbi.nlm.nih.gov/pubmed/30598897

100.

Colli

Manzan

Besola

et al. One-year outcomes after transapical echocardiography-guided mitral valve repair. Circulation 2018; 138: 843–845.doi:10.1161/CIRCULATIONAHA.118.033509

http://www.ncbi.nlm.nih.gov/pubmed/30359126

101.

Colli

Manzan

Aidietis

et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg 2018; 54: 460–466.doi:10.1093/ejcts/ezy064

http://www.ncbi.nlm.nih.gov/pubmed/29514183

102.

Gammie

JS.

Wilson

Bartus

et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation 2016; 134: 189–197.doi:10.1161/CIRCULATIONAHA.116.022010

http://www.ncbi.nlm.nih.gov/pubmed/27436878

103.

Gerosa

D'Onofrio

Besola

et al. Transoesophageal echo-guided mitral valve repair using the Harpoon system. Eur J Cardiothorac Surg 2018; 53: 871–873.doi:10.1093/ejcts/ezx365

http://www.ncbi.nlm.nih.gov/pubmed/29092010

104.

Gammie

JS.

Bartus

Gackowski

et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a Trial. J Am Coll Cardiol 2018; 71: 25–36.doi:10.1016/j.jacc.2017.10.062

http://www.ncbi.nlm.nih.gov/pubmed/29102688

105.

Weber

Rucinskas

Janusauskas

et al. Automated implantation of artificial mitral chords: preliminary results from the feasibility trial. Ann Thorac Surg 2020; 109: 597–602.doi:10.1016/j.athoracsur.2019.08.037

http://www.ncbi.nlm.nih.gov/pubmed/31563490

106.

Cheung

Webb

JG.

Barbanti

et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol 2013; 61: 1759–1766.doi:10.1016/j.jacc.2013.01.058

23500301

107.

Cheung

Yamashita

et al. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC Cardiovasc Interv 2015; 8: 1735–1744.doi:10.1016/j.jcin.2015.08.012

http://www.ncbi.nlm.nih.gov/pubmed/26476608

108.

Ranney

DN.

Williams

JB.

Wang

et al. Valve-in-valve transcatheter valve implantation in the nonaortic position. J Card Surg 2016; 31: 282–288.doi:10.1111/jocs.12745

http://www.ncbi.nlm.nih.gov/pubmed/27059552

109.

Bouleti

Fassa

A-A.

Himbert

et al. Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. JACC Cardiovasc Interv 2015; 8: 83–91.doi:10.1016/j.jcin.2014.07.026

25616821

110.

Chen

Cheng

et al. Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: a systematic review and meta-analysis. J Card Surg 2018; 33: 508–519.doi:10.1111/jocs.13767

http://www.ncbi.nlm.nih.gov/pubmed/29989214

111.

Lloyd

JW.

Joseph

TA.

Cabalka

et al. Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring. Catheter Cardiovasc Interv 2019; 94: 458–466.doi:10.1002/ccd.28149

http://www.ncbi.nlm.nih.gov/pubmed/30790436

112.

Keenan

NM.

Bennetts

JS.

McGavigan

et al. Transcatheter transseptal mitral valve-in-valve replacement: an early Australian case series and literature review. Heart Lung Circ 2020; 29: 921–930.doi:10.1016/j.hlc.2019.07.010

http://www.ncbi.nlm.nih.gov/pubmed/31526680

113.

da Costa

LPN.

Palma

JH.

Barbosa Ribeiro

et al. Transcatheter mitral valve-in-valve implantation: reports of the first 50 cases from a Latin American centre. Interact Cardiovasc Thorac Surg 2020; 30: 229–235.doi:10.1093/icvts/ivz265

http://www.ncbi.nlm.nih.gov/pubmed/31713609

114.

Lipinski

Patel

SM.

Patel

et al. Transcatheter valve implantation for failed surgical aortic and mitral bioprostheses: a single-center experience. J Invasive Cardiol 2020; 32: 186–193.http://www.ncbi.nlm.nih.gov/pubmed/32160153

115.

Flynn

CD.

Wilson-Smith

AR.

Yan

. Novel mitral valve technologies-transcatheter mitral valve implantation: a systematic review. Ann Cardiothorac Surg 2018; 7: 716–723.doi:10.21037/acs.2018.11.01

http://www.ncbi.nlm.nih.gov/pubmed/30598884

116.

Urena

Brochet

Lecomte

et al. Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience. Eur Heart J 2018; 39: 2679–2689.doi:10.1093/eurheartj/ehy271

http://www.ncbi.nlm.nih.gov/pubmed/29788044

117.

Werner

Kilkowski

Sutor

et al. Transcatheter mitral valve implantation (TMVI) using Edwards SAPIEN 3 prostheses in patients at very high or prohibitive surgical risk: a single-center experience. J Interv Cardiol 2020; 2020: 1–11.doi:10.1155/2020/9485247

http://www.ncbi.nlm.nih.gov/pubmed/31992963

118.

Elmously

Worku

Gray

et al. Mitral valve-in-valve implantation as an elective or rescue procedure in high-risk patients. Ann Thorac Surg 2018; 105: 1778–1783.doi:10.1016/j.athoracsur.2017.12.036

http://www.ncbi.nlm.nih.gov/pubmed/29382511

119.

Yamashita

Fukushima

Shimahara

et al. Early outcomes of transcatheter mitral valve replacement for degenerated bioprosthesis in Japanese (MITRAL VIV study): a four-case series. Gen Thorac Cardiovasc Surg 2020; 68: 1–8.doi:10.1007/s11748-019-01147-x

http://www.ncbi.nlm.nih.gov/pubmed/31129791

120.

Okoh

AK.

Shah

Kang

et al. Outcomes after transcatheter mitral valve-in-valve replacement in patients with degenerated bioprosthesis: a single-center experience. J Invasive Cardiol 2020; 32: 49–54.http://www.ncbi.nlm.nih.gov/pubmed/31724535

121.

Long

Mahoney

. Transcatheter mitral valve-in-valve and valve-in-ring replacement in high-risk surgical patients: feasibility, safety, and longitudinal outcomes in a single-center experience. J Invasive Cardiol 2018; 30: 324–328.http://www.ncbi.nlm.nih.gov/pubmed/29906265

122.

Kamioka

Babaliaros

Morse

et al. Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy. JACC Cardiovasc Interv 2018; 11: 1131–1138.doi:10.1016/j.jcin.2018.03.011

http://www.ncbi.nlm.nih.gov/pubmed/29929633

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.04 MB

0.90 MB

0.00 MB